These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 16858611

  • 21. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M, Noschese P, Vinciguerra A, Di Perna F, Califano C, Berra A.
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [Abstract] [Full Text] [Related]

  • 22. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J, Dofferhoff AS, Mouton JW, van der Meer JW.
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [Abstract] [Full Text] [Related]

  • 23. Intermittent administration of ceftazidime to burns patients: influence of glomerular filtration.
    Conil JM, Georges B, Fourcade O, Seguin T, Houin G, Saivin S.
    Int J Clin Pharmacol Ther; 2007 Mar; 45(3):133-42. PubMed ID: 17416108
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ, Smith MD, Suputtamongkol Y, Mattie H, Walsh AL, Wuthiekanun V, Chaowagul W, White NJ.
    Br J Clin Pharmacol; 2000 Aug; 50(2):184-91. PubMed ID: 10930972
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of ceftazidime in dogs following subcutaneous administration and continuous infusion and the association with in vitro susceptibility of Pseudomonas aeruginosa.
    Moore KW, Trepanier LA, Lautzenhiser SJ, Fialkowski JP, Rosin E.
    Am J Vet Res; 2000 Oct; 61(10):1204-8. PubMed ID: 11039548
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ, Smith MD, Suputtamongkol Y, Mattie H, Walsh AL, Wuthiekanun V, Chaowagul W, White NJ.
    Br J Clin Pharmacol; 2000 May; 49(5):445-52. PubMed ID: 10792202
    [Abstract] [Full Text] [Related]

  • 27. Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis.
    Hubert D, Le Roux E, Lavrut T, Wallaert B, Scheid P, Manach D, Grenet D, Sermet-Gaudelus I, Ramel S, Cracowski C, Sardet A, Wizla N, Deneuville E, Garraffo R.
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3650-6. PubMed ID: 19528265
    [Abstract] [Full Text] [Related]

  • 28. Intermittent bolus dosing of ceftazidime in critically ill patients.
    Young RJ, Lipman J, Gin T, Gomersall CD, Joynt GM, Oh TE.
    J Antimicrob Chemother; 1997 Aug; 40(2):269-73. PubMed ID: 9301994
    [Abstract] [Full Text] [Related]

  • 29. Continuous infusion of ceftazidime in the empiric treatment of febrile neutropenic children with cancer.
    Dalle JH, Gnansounou M, Husson MO, Lambilliotte A, Mazingue F, Nelken B.
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):714-6. PubMed ID: 12468910
    [Abstract] [Full Text] [Related]

  • 30. Continuous infusion of ceftazidime with an elastomeric infusion device.
    Couldry R, Sanborn M, Klutman NE, Strayer AH.
    Am J Health Syst Pharm; 1998 Jan 15; 55(2):145-9. PubMed ID: 9465978
    [Abstract] [Full Text] [Related]

  • 31. [Continuous ceftazidime infusion in the treatment of Pseudomonas aeruginosa infections in a Hospital at Home Unit].
    Laghzaoui F, Murcia J, Llorens P, Portilla J.
    Enferm Infecc Microbiol Clin; 2007 Jan 15; 25(1):71-2. PubMed ID: 17261252
    [No Abstract] [Full Text] [Related]

  • 32. Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs.
    Goldstein I, Wallet F, Robert J, Becquemin MH, Marquette CH, Rouby JJ.
    Am J Respir Crit Care Med; 2002 Jan 15; 165(2):171-5. PubMed ID: 11790649
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats.
    Albarellos GA, Ambros LA, Landoni MF.
    Vet J; 2008 Nov 15; 178(2):238-43. PubMed ID: 17768077
    [Abstract] [Full Text] [Related]

  • 34. Nebulization of Vancomycin Provides Higher Lung Tissue Concentrations than Intravenous Administration in Ventilated Female Piglets with Healthy Lungs.
    Morais CLM, Nascimento JWL, Ribeiro AC, Cortinez LI, Carmona MJC, Maia DRR, Monsel A, Auler JOC, Rouby JJ, Otsuki DA.
    Anesthesiology; 2020 Jun 15; 132(6):1516-1527. PubMed ID: 32053565
    [Abstract] [Full Text] [Related]

  • 35. Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia.
    McNabb JJ, Nightingale CH, Quintiliani R, Nicolau DP.
    Pharmacotherapy; 2001 May 15; 21(5):549-55. PubMed ID: 11349744
    [Abstract] [Full Text] [Related]

  • 36. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J.
    J Antimicrob Chemother; 2009 Jul 15; 64(1):142-50. PubMed ID: 19398460
    [Abstract] [Full Text] [Related]

  • 37. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C, Venet C, Jehl F, Mwewa S, Lazarevic V, Diconne E, Fonsale N, Carricajo A, Guyomarc'h S, Vermesch R, Aubert G, Bidault R, Bertrand JC, Zeni F.
    Crit Care; 2006 Feb 15; 10(1):R26. PubMed ID: 16507147
    [Abstract] [Full Text] [Related]

  • 38. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
    Rafati MR, Rouini MR, Mojtahedzadeh M, Najafi A, Tavakoli H, Gholami K, Fazeli MR.
    Int J Antimicrob Agents; 2006 Aug 15; 28(2):122-7. PubMed ID: 16815689
    [Abstract] [Full Text] [Related]

  • 39. Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats.
    Miglioli PA, Xerri L, Palatini P.
    Pharmacology; 1991 Aug 15; 43(5):242-6. PubMed ID: 1784624
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.